Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30892213 | 0.83 | CA12 (0.56) | CYP1B1CA12CA1CA2CA7 | |
| SCHEMBL12463621 | 0.83 | CA12 (0.56) | CYP1B1CA12CA1CA2CA7 | |
| SCHEMBL11933957 | 0.83 | CYP1B1 (0.44) | CYP1B1CA12CA1CA2CA7 | |
| SCHEMBL14074156 | 0.81 | HPGD (0.63) | CYP1B1CA12CA1CA2CA9 | |
| SCHEMBL1547455 | 0.81 | CA12 (0.58) | CYP1B1CA12CA1CA2CA7 | |
| SCHEMBL9970729 | 0.81 | TUBB4A (0.46) | CYP1B1CA12CA1CA2CA7 | |
| SCHEMBL8421873 | 0.79 | SMN1; SMN2 (0.42) | CYP1B1CA12CA1CA2CA7 | |
| SCHEMBL13888877 | 0.79 | ACHE (0.56) | CYP1B1ALDH1A1CYP3A4KMT2AMAPT | |
| SCHEMBL22281456 | 0.79 | CYP1B1 (0.42) | CYP1B1CA12CA1CA2CA7 | |
| SCHEMBL10279315 | 0.79 | CA12 (0.56) | CYP1B1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851685-B2 | Zwitterion buffer containing compositions and uses in electroanalytical devices and methods | ROCHE DIABETES CARE, INC. (US) | 2023-12-26 | — | — | US | claimed |
| US-5858691-A | Method and agent for the simultaneous colorimetric and electrochemical measurement of an analyte | BOEHRINGER MANNHEIM GMBH (DE) | 1999-01-12 | — | — | US | claimed |
| EP-4481375-A2 | DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME | F. Hoffmann-La Roche AG (CH) | 2024-12-25 | — | — | EP | disclosed |
| EP-3523639-B1 | DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME | HOFFMANN LA ROCHE (CH) | 2024-12-18 | — | — | EP | disclosed |
| US-20240327892-A1 | DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME | ROCHE DIABETES CARE, INC. | 2024-10-03 | — | — | US | disclosed |
| US-12024735-B2 | Detection reagents and electrode arrangements for multi-analyte diagnostic test elements, as well as methods of using the same | ROCHE DIABETES CARE, INC. (US) | 2024-07-02 | — | — | US | disclosed |
| US-11851685-B2 | Zwitterion buffer containing compositions and uses in electroanalytical devices and methods | ROCHE DIABETES CARE, INC. (US) | 2023-12-26 | — | — | US | disclosed |
| EP-4152003-A1 | SYSTEMS AND METHODS FOR MULTIPLE ANALYTE ANALYSIS | Roche Diabetes Care GmbH (DE) | 2023-03-22 | — | — | EP | disclosed |
| EP-3757574-B1 | SYSTEMS AND METHODS FOR MULTIPLE ANALYTE ANALYSIS | ROCHE DIABETES CARE GMBH (DE) | 2022-12-07 | — | — | EP | disclosed |
| US-20220275348-A1 | ZWITTERION BUFFER CONTAINING COMPOSITIONS AND USES IN ELECTROANALYTICAL DEVICES AND METHODS | ROCHE DIABETES CARE, INC. | 2022-09-01 | — | — | US | disclosed |
| US-20220098636-A1 | DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME | ROCHE DIABETES CARE, INC. (US) | 2022-03-31 | — | — | US | disclosed |
| EP-0441222-B1 | Process and electrode system for determining an analyte or an oxidoreductase as well as suitable compounds | BOEHRINGER MANNHEIM GMBH (DE) | 1996-12-18 | — | — | EP | disclosed |
| US-5484708-A | DETERMINATION OF GLUCOSE | BOEHRINGER MANNHEIM GMBH (DE) | 1996-01-16 | — | — | US | disclosed |
| CN-1098745-A | Method with PQQ-dependent dehydrogenase colorimetric estimation analyte | BOEHRINGER MANNHEIM GMBH (DE) | 1995-02-15 | — | — | CN | disclosed |
| EP-0620283-A1 | Method for colourimetric determination of an analyte by using a PQQ-dependent dehydrogenase | Roche Diagnostics GmbH (DE) | 1994-10-19 | — | — | EP | disclosed |
| CN-1026248-C | Method and sensing electrode system for electrochemical determination of analytes and oxidoreductases | BOEHRINGER MANNHEIM GMBH | 1994-10-19 | — | — | CN | disclosed |
| US-5286362-A | Reducible substance is enzymatically reduced and oxidized at the electrode; substance formed by oxidation is different from the reducible substance used initially | BOEHRINGER MANNHEIM GMBH (DE) | 1994-02-15 | — | — | US | disclosed |
| US-5122244-A | Having a reducible nitroso or oxime compound to transfer electrons leading to a signal and form an aromatic amine oxidizable to a compound different from the original; low voltage | BOEHRINGER MANNHEIM GMBH (DE) | 1992-06-16 | — | — | US | disclosed |
| CN-1054666-A | Be used for the method for electrochemical determination of analyte or oxidoreducing enzyme and sensitive electrode system and for this reason and the compound that uses | BOEHRINGER MANNHEIM GMBH (DE) | 1991-09-18 | — | — | CN | disclosed |
| EP-0441222-A2 | Process and electrode system for determining an analyte or an oxidoreductase as well as suitable compounds | Roche Diagnostics GmbH (DE) | 1991-08-14 | — | — | EP | disclosed |